3 Stocks Pushing The Health Services Industry Higher
All three major indices are trading down today with the
Dow Jones Industrial Average
(
^DJI
) trading down 24 points (-0.1%) at 18,483 as of Friday, July 15, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,378 issues advancing vs. 1,527 declining with 156 unchanged.
The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.3%. Top gainers within the industry include
(
), up 0.8%, and
(
), up 0.8%. On the negative front, top decliners within the industry include
(
), down 1.2%,
(
), down 0.9%,
(
), down 0.8%,
(
), down 0.7% and
(
), down 0.5%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
(
) is one of the companies pushing the Health Services industry higher today. As of noon trading, Ironwood Pharmaceuticals is up $0.87 (6.9%) to $13.42 on heavy volume. Thus far, 1.3 million shares of Ironwood Pharmaceuticals exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $12.62-$13.72 after having opened the day at $12.86 as compared to the previous trading day's close of $12.55.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Ironwood Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, and commercialization of human therapeutic products. Ironwood Pharmaceuticals has a market cap of $1.8 billion and is part of the health care sector. Shares are up 8.3% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts who rate Ironwood Pharmaceuticals a buy, no analysts rate it a sell, and 4 rate it a hold.
TheStreet Ratings rates
Ironwood Pharmaceuticals
as a
. The company's weaknesses can be seen in multiple areas, such as its poor profit margins and generally high debt management risk. Get the full
Ironwood Pharmaceuticals Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $3.44 (8.7%) to $42.89 on heavy volume. Thus far, 2.9 million shares of Alere exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $41.55-$43.16 after having opened the day at $41.57 as compared to the previous trading day's close of $39.45.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Alere Inc. provides point-of-care diagnostics and services for infectious disease, cardiometabolic disease, and toxicology in the United States and internationally. The company operates through Professional Diagnostics and Consumer Diagnostics segments. Alere has a market cap of $3.4 billion and is part of the health care sector. Shares are up 0.9% year-to-date as of the close of trading on Thursday. Currently there are 2 analysts who rate Alere a buy, no analysts rate it a sell, and 3 rate it a hold.
TheStreet Ratings rates
Alere
as a
. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally higher debt management risk. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $2.51 (1.9%) to $132.52 on heavy volume. Thus far, 1.3 million shares of Cigna exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $130.04-$133.48 after having opened the day at $130.47 as compared to the previous trading day's close of $130.01.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through three segments: Global Health Care, Global Supplemental Benefits, and Group Disability and Life. Cigna has a market cap of $33.4 billion and is part of the health care sector. Shares are down 11.2% year-to-date as of the close of trading on Thursday. Currently there are 7 analysts who rate Cigna a buy, 1 analyst rates it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Cigna
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).